CG vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

CG

58.5
AI Score
VS
IVZ Wins

IVZ

59.6
AI Score

Investment Advisor Scores

CG

59score
Recommendation
HOLD

IVZ

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CG IVZ Winner
Forward P/E 11.1857 11.2994 CG
PEG Ratio 0.9903 0.9008 IVZ
Revenue Growth -94.1% 14.1% IVZ
Earnings Growth 70.2% 35.0% CG
Tradestie Score 58.5/100 59.6/100 IVZ
Profit Margin 16.8% -3.7% CG
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CG 1M: +14.2% · 3M: -1.1% IVZ 1M: +13.3% · 3M: +18.3%

Current Technical Phase

CG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.5 · Price: $48.92

IVZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.8% over 20 days), RSI 60

RSI (14): 60.2 · Price: $30.62

Fundamentals Snapshot

Metric CG IVZ
Market Cap
Forward P/E 9.6 9.2
Trailing P/E 31.5
Revenue (TTM)
Revenue Growth -0.9% 0.2%
Gross Margin 0.9% 0.3%
Operating Margin -2.3% 0.2%
EPS 1.46 -1.40
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.